Table 3.
Univariate |
Multivariate |
|||||
---|---|---|---|---|---|---|
HR | 95% CI | p values | HR | 95% CI | p values | |
Male | 1.47 | 0.83–2.61 | 0.1900 | |||
Age <40 years | 1.97 | 1.18–3.31 | 0.0095 | 5.23 | 1.46–18.77 | 0.0112 |
Age ≥60 years | 2.62 | 1.61–4.24 | 0.0001 | 4.10 | 1.41–11.89 | 0.0094 |
Tumor >4 cm | 2.73 | 1.68–4.46 | 0.0001 | |||
Ex2 | 2.58 | 1.60–4.15 | 0.0001 | |||
cN1b | 3.63 | 2.25–5.84 | <0.0001 | 2.82 | 1.20–6.65 | 0.0178 |
Aggressive type | 5.81 | 3.58–9.43 | <0.0001 | 2.13 | 0.84–5.41 | 0.1100 |
Ki-67 LI >10% | 6.34 | 3.72–10.79 | <0.0001 | 15.33 | 4.13–56.96 | 0.00005 |
Ki-67 LI 5–10% | 3.47 | 2.06–5.85 | <0.0001 | 9.33 | 2.98–29.21 | 0.00013 |
Biochemically PD | 12.04 | 6.31–22.99 | <0.0001 | excluded | ||
Tg-DT <2 years | 13.54 | 6.16–29.76 | <0.0001 | excluded |
HR = Hazard ratio; CI = confidence interval; Ex2 = significant extrathyroid extension; Biochemically PD = biochemically persistent disease; Tg-DT = thyroglobulin doubling time. For the multivariate analysis, biochemically PD and Tg-DT were excluded from the analysis because these factors were strongly associated with Ki-67 LI.